Production (Stage)
FibroBiologics, Inc.
FBLG
$0.8087
-$0.0638-7.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.03% | 78.68% | 31.04% | -26.78% | -10.97% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 185.33% | -36.26% | -31.85% | -30.56% | 1,972.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 12.50% |
| Total Current Assets | -34.45% | 73.55% | 25.95% | -27.05% | -3.18% |
|
|
|||||
| Total Current Assets | -34.45% | 73.55% | 25.95% | -27.05% | -3.18% |
| Net Property, Plant & Equipment | -5.32% | -2.38% | -5.49% | -2.99% | -4.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -30.52% | 57.08% | 17.47% | -21.82% | -3.57% |
|
|
|||||
| Total Accounts Payable | -47.46% | 128.75% | -2.40% | 48.40% | -43.63% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -36.31% | 7,872.17% | -59.93% | -37.47% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.74% | 2.30% | 2.62% | 2.69% | 2.76% |
| Total Finance Division Other Current Liabilities | 18.04% | -90.78% | -39.54% | -33.10% | 67.28% |
| Total Other Current Liabilities | 18.04% | -90.78% | -39.54% | -33.10% | 67.28% |
| Total Current Liabilities | -35.48% | 90.59% | -34.10% | -27.55% | 52.29% |
|
|
|||||
| Total Current Liabilities | -35.48% | 90.59% | -34.10% | -27.55% | 52.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -36.31% | 7,872.17% | -59.93% | -37.47% | -- |
| Capital Leases | -12.09% | -6.73% | -9.60% | -8.61% | -7.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -33.80% | 77.32% | -31.57% | -25.97% | 44.42% |
|
|
|||||
| Common Stock & APIC | 11.98% | 8.81% | 19.04% | 2.00% | 13.06% |
| Retained Earnings | -13.98% | -9.56% | -1.57% | 2.74% | -34.73% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -14.08% | -0.07% | 214.66% | 38.21% | -408.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.08% | -0.07% | 214.66% | 38.21% | -408.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.08% | -0.07% | 214.66% | 38.21% | -408.30% |
|
|
|||||